Mergers & Acquisitions
Jun. 7, 2013
Dealmakers
A roundup of recent mergers and acquisitions and financing activity and the lawyers involved.
Firms advise on $11M sale of Buphenyl Tablets and Powder from Ucyclyd
Hogan Lovells represented South San Francisco-based biopharmaceutical company Hyperion Therapeutics Inc. in its acquisition of Buphenyl Tablets and Powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals International Inc. DLA Piper represented Ucyclyd.
The completion of the $11 million sale was announced June 3. B...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In